<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Functional neurological symptom disorder (conversion disorder) in adults: Epidemiology, pathogenesis, and prognosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Functional neurological symptom disorder (conversion disorder) in adults: Epidemiology, pathogenesis, and prognosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Functional neurological symptom disorder (conversion disorder) in adults: Epidemiology, pathogenesis, and prognosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jon Stone, FRCP, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Sharpe, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joel Dimsdale, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 01, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H13157530"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Functional neurological symptom disorder (conversion disorder) is characterized by neurologic symptoms such as abnormal movements, nonepileptic seizures, or weakness, which involve abnormal nervous system functioning rather than structural disease [<a href="#rid1">1</a>]. In addition, clinical findings on examination provide evidence of incompatibility between the symptoms and recognized neurologic disease. Nevertheless, functional neurological symptom disorder causes distress and/or functional impairment, and is common in clinical settings and often has a poor prognosis [<a href="#rid2">2-5</a>].</p><p>This topic reviews the epidemiology, pathogenesis, and prognosis of functional neurological symptom disorder. The terminology, diagnosis, differential diagnosis, clinical features, assessment, and treatment are discussed separately, as are specific subtypes of functional neurological symptom disorder (psychogenic nonepileptic seizures and functional movement disorders):</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14826.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Terminology, diagnosis, and differential diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/85765.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Clinical features, assessment, and comorbidity"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/85766.html" rel="external">"Functional neurological symptom disorder (conversion disorder) in adults: Treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">"Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14132.html" rel="external">"Functional movement disorders"</a>.)</p><p></p><p class="headingAnchor" id="H13156061"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>The incidence and prevalence of functional neurological symptom disorder (conversion disorder) has been more widely studied in clinical settings than in the general population.</p><p class="headingAnchor" id="H13156068"><span class="h2">General population</span><span class="headingEndMark"> — </span>Establishing case rates in population studies is difficult because the diagnosis is usually made in secondary care. It is thus likely that published rates underestimate the true numbers.</p><p>A review found that the estimated incidence of functional neurological symptom disorder across disparate geographical settings was 4 to 12 per 100,000 per year (0.004 to 0.012 percent), and the community prevalence was 50 per 100,000 per year (0.05 percent) [<a href="#rid6">6</a>].</p><p class="headingAnchor" id="H13156075"><span class="h2">Neurologic settings</span><span class="headingEndMark"> — </span>The prevalence of functional neurologic symptoms in neurologic settings ranges from 9 to 16 percent, making it one of the most common disorders:</p><p class="bulletIndent1"><span class="glyph">●</span>A prospective, 15-month study of 3781 new neurology outpatients found that functional neurological symptom disorder was present in 16 percent, and was the second most common neurologic presentation [<a href="#rid2">2</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A prospective, 17-month study of 884 new neurology outpatients found that functional neurological symptom disorder was present in 15 percent, and was the third most common neurologic presentation [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective, three-year study of hospitalizations on a neurology service (n = 1949) found that functional neurological symptom disorder represented 9 percent of all admissions [<a href="#rid8">8</a>].</p><p></p><p class="headingAnchor" id="H4024185102"><span class="h2">Emergency medicine settings</span><span class="headingEndMark"> — </span>A retrospective, one-year study of 213 emergency department presentations, with seizures more than five minutes long and/or more than two seizures in 24 hours (status epilepticus), found that 114 (54 percent) received a final diagnosis of functional seizures [<a href="#rid9">9</a>]. Among the 114 presentations with functional seizures, only 15 percent were initially recognized correctly.</p><p class="headingAnchor" id="H13156082"><span class="h2">Sociodemographic correlates</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age</strong> – In a meta-analysis of patient-level data from nearly 5000 cases of functional neurological symptom disorder with abnormal movement, the mean age at onset was approximately 40 years [<a href="#rid10">10</a>]. Although functional neurological symptom disorder has been reported in patients of all ages, it is rarely diagnosed before age 10 years [<a href="#rid11">11,12</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sex</strong> – Multiple studies indicate that functional neurological symptom disorder is more likely to occur in females than males [<a href="#rid10">10,13-15</a>]. As an example, a meta-analysis of nearly 5000 patients with the disorder (abnormal movement subtype) found that 73 percent were female [<a href="#rid10">10</a>]. However, in some subgroups such as older patients and patients with certain types of functional movement disorders (eg, jerky movements), males are more commonly affected.</p><p></p><p class="headingAnchor" id="H2577699895"><span class="h2">Health care costs</span><span class="headingEndMark"> — </span>A United States study of health care costs in 30 million adults in 2017 found that functional neurological symptom disorders were associated with annual costs of $1066 million for inpatient care, which were comparable to costs associated with anterior horn cell disease [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H13156089"><span class="h1">ETIOLOGY AND PATHOGENESIS</span><span class="headingEndMark"> — </span>The etiology and pathogenesis of functional neurological symptom disorder (conversion disorder) is not fully understood, despite an increase in the number of reproducible research findings. Many biological, psychological, and social factors have been found to be more common in patients with functional neurological symptom disorder than patients with comparable symptoms due to recognized disease [<a href="#rid16">16-18</a>]. While each of these factors may play a role in predisposing patients to functional neurological symptom disorder, precipitating its onset, and/or perpetuating it once it has arisen, caution is required before assuming that these associations are causal (<a class="graphic graphic_table graphicRef88079" href="/z/d/graphic/88079.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H13156103"><span class="h2">Predisposing, precipitating, and perpetuating factors</span><span class="headingEndMark"> — </span>Psychological factors such as stressful life events, interpersonal conflicts, and adverse childhood experience have traditionally been considered the “cause” of functional neurological symptom disorder. It was thought that these factors were converted into neurologic symptoms, hence the older name “conversion disorder.” However, patients with the disorder do not always report psychological factors, nor are they specific to functional neurological symptom disorder. In addition, “stress” is ubiquitous and adverse childhood experiences are common in the general population. Although psychological factors are often associated with functional neurological symptom disorder, this does not prove that the factors cause the disorder (correlation is not causation) [<a href="#rid19">19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 34 retrospective studies examined the history of stressful life events and maltreatment in patients with functional neurological symptom disorder (n &gt;1400) and in healthy or patient controls (n &gt;2200) [<a href="#rid19">19</a>]. Stressful life events were more common in patients with functional neurological symptom disorder than controls (odds ratio 2.8, 95% CI 1.4-6.0). In addition, maltreatment had occurred in more patients than controls:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Emotional neglect (49 versus 20 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Sexual abuse (24 versus 10 percent)</p><p class="bulletIndent2"><span class="glyph">•</span>Physical abuse (30 versus 12 percent)</p><p></p><p class="bulletIndent1">Among the 34 studies, 13 found that some patients with functional neurological symptom disorder, ranging from 14 to 70 percent, had no history of either stressful life events or any type of maltreatment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a subsequent retrospective study of 322 patients with functional neurological symptom disorder (weakness or abnormal movements) and 644 psychiatric control patients, the proportion of patients with a history of childhood sexual abuse was similar in both groups (20 and 22 percent), as was the proportion with a history of physical abuse (23 and 22 percent) [<a href="#rid13">13</a>].</p><p></p><p>Pre-existing psychiatric, medical and neurologic conditions may also predispose patients to developing functional neurological symptom disorder [<a href="#rid16">16</a>]. Compared with controls with recognizable diseases, patients with functional neurological symptom disorder are more likely to have a history of pre-existing psychiatric disorders (eg, depressive, anxiety, and personality disorders), other somatic conditions (eg, pain, fatigue, and cognitive impairment) [<a href="#rid13">13,20,21</a>], or other types of preexisting functional somatic disorders, such as irritable bowel syndrome [<a href="#rid22">22</a>]. In addition, functional neurological symptom disorder is often preceded by neurologic illnesses (eg, migraine, epilepsy, peripheral nerve pathology, or stroke) that appear to precede, but do not explain the functional neurologic symptoms [<a href="#rid23">23,24</a>]. Physical injury may also precede functional neurologic symptoms [<a href="#rid25">25,26</a>]. Further, functional neurological symptom disorder is associated with lower socioeconomic status [<a href="#rid15">15</a>].</p><p>It is not clear if symptom modeling (exposure to similar symptoms in others) is a pathogenic factor. Some studies of functional neurological symptom disorder indicate it is associated with symptom modeling [<a href="#rid27">27-29</a>], but others do not [<a href="#rid30">30-32</a>]. As an example, a study of 132 patients with functional movement disorders and 148 healthy controls found that the proportion of health care workers in each group was comparable (25 and 20 percent) [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H13165779"><span class="h2">Other perpetuating factors</span><span class="headingEndMark"> — </span>Functional neurological symptom disorder may be perpetuated if the patient is unable to understand or agree with the diagnosis. The concept that the disorder is at least potentially reversible, and that rehabilitation may help is an essential basis for further treatment.</p><p>Clinicians may perpetuate the condition in multiple ways, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Failing to give a clear explanation and positive diagnosis of the symptoms [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Excessively investigating symptoms [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Allowing patients to visit different specialists without anyone taking primary responsibility [<a href="#rid36">36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prescribing inappropriate drugs such as opiates for pain, and providing appliances such as crutches and wheelchairs at a point when these might interfere with rehabilitation [<a href="#rid37">37</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Performing unnecessary operations.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Misattributing symptoms to recognizable disease or to irrelevant radiologic or laboratory findings (eg, age-related degenerative changes in the vertebrae) [<a href="#rid38">38</a>].</p><p></p><p>In addition, functional neurologic symptoms may be perpetuated by progressive physical deconditioning, untreated comorbid psychiatric disorders, disability-related financial benefits, and ongoing litigation [<a href="#rid39">39,40</a>]. Another potential perpetuating factor is ongoing life stress (eg, work or family) that was relieved by onset of the disorder and would probably recur if the patient was to recover. However the significance of this so-called “secondary gain” was overstated in the past [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H13156110"><span class="h2">Etiologic hypotheses</span><span class="headingEndMark"> — </span>Different hypothetical models attempt to explain how conversion symptoms develop; the models are not mutually exclusive.</p><p class="headingAnchor" id="H13156124"><span class="h3">Cognitive-behavioral models</span><span class="headingEndMark"> — </span>Multiple overlapping cognitive-behavioral models endeavor to explain the etiology and pathogenesis of functional neurological symptom disorder.</p><p>One cognitive-behavioral model is based upon findings that processing of perception and behavior mostly occurs outside of awareness, and proposes that functional neurologic symptoms may result from cognitive, emotional, and behavioral influences at these lower levels of processing [<a href="#rid42">42</a>]. It is suggested that patients with the disorder initially encounter (in themselves or others) a stimulus for a particular symptom, such as mild weakness from migraine. This involuntarily generates a mental representation or memory of paralysis. Excessive anxiety about becoming paralyzed, and/or hypervigilance in looking for evidence (eg, weakness) of paralysis in oneself, may activate the mental representation to the point that it overrides sensory input and distorts awareness and behavior [<a href="#rid43">43</a>].</p><p>Another cognitive-behavioral model proposes that functional neurological symptom disorder involves dissociative experiences [<a href="#rid44">44</a>]. Dissociation is subjectively perceived as disconnection from oneself (depersonalization) or the environment (derealization). During dissociation, awareness and integration of thoughts, feelings, memories, and identity is altered, as is integration of somatic experiences and functions, and patients lose functioning of motor control or sensory awareness [<a href="#rid45">45</a>]. Dissociation may occur as a consequence of fatigue, panic attacks [<a href="#rid46">46</a>], physical injuries [<a href="#rid25">25,26,47</a>], recognizable diseases [<a href="#rid23">23,48</a>], pain [<a href="#rid49">49</a>], general anesthesia [<a href="#rid46">46,50</a>], or drug side effects [<a href="#rid26">26</a>]. According to this model, the symptom of paralysis or abnormal movement arises during the dissociated state when the patient is “depersonalized” and generally loses feelings of ownership over body movements. Attention focused upon this experience, combined with fear of what the symptom might represent (eg, stroke), may intensify and cause more “localized” depersonalization in one body part, thus prolonging the symptom. In functional seizures, prodromal symptoms of autonomic arousal may become so unbearable that patients respond by losing awareness in an apparent blackout [<a href="#rid51">51-54</a>]. Some studies of patients with functional neurological symptom disorder suggest that their explicit awareness of emotional symptoms, such as anxiety, is low, which may help explain why they are more likely to report physical but not emotional content of these events [<a href="#rid55">55,56</a>], with subsequent nonepileptic seizures occurring as a conditioned response to unpleasant thoughts, feelings, and situations, even in the absence of a prodrome. In functional limb weakness, weakness and numbness may occur as a maladaptive response in an attempt to reduce pain through dissociation [<a href="#rid49">49</a>]; this may explain the clinical overlap seen with complex regional pain syndrome [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H13156131"><span class="h3">Neurobiologic models</span><span class="headingEndMark"> — </span>Functional neurological symptom disorder may involve abnormalities in neural networks of grey matter brain regions rather than a disturbance in one specific structure [<a href="#rid44">44</a>]. These networks are thought to include frontal (orbitofrontal and anterior cingulate cortex) and subcortical (limbic) structures that may be activated by stress and other factors, and in turn provide input to inhibitory basal ganglia-thalamocortical circuits that reduce conscious motor or sensory processing [<a href="#rid58">58,59</a>]. Functional magnetic resonance imaging (MRI) comparing patients with functional neurological symptom disorder (weakness subtype) with healthy controls during recall of traumatic events have found differences in regional brain activity (eg, prefrontal cortex and hippocampus) [<a href="#rid60">60</a>], which in other studies correlated with symptom severity [<a href="#rid61">61</a>].</p><p>In addition, there may be aberrant activity in brain networks that include the inferior parietal lobe/temporoparietal junction, which are involved in self-agency, the sense that one causes one’s own actions [<a href="#rid58">58,62,63</a>]. One hypothesis is that overly sensitive amygdala responses to fear (ie, abnormal responses to stimuli, including those that are objectively neutral) lead to changes in networks mediating sensory and motor function. In the setting of abnormal self-directed attention (eg, depersonalization occurring at the time of injury or panic), these changes produce sensations or movements that are associated with an abnormal sense of self control and are interpreted as involuntary symptoms of a disease [<a href="#rid43">43,44</a>].</p><p>Neuroimaging of patients with functional neurological symptom disorder also suggests possible structural changes in the brain. As an example, structural MRI studies that compared patients with controls found evidence of altered brain structure in patients (eg, increased thalamic volume and decreased sensorimotor cortical thickness) [<a href="#rid64">64,65</a>]. However, it is not known if these differences indicate causal factors, confounding comorbidities, or sequelae of the disorder.</p><p>Other studies have examined endocrine and inflammatory profiles in patients with functional neurological symptom disorder. Although multiple studies of basal and task related cortisol levels in patients found few differences from healthy controls [<a href="#rid66">66</a>], the studies were too small to draw clear conclusions.</p><p>The concept of “active inference” suggests that the brain operates on a moment-to-moment basis by making predictions in advance rather than just sensing and responding. It has been proposed that functional neurological symptom disorder arises when patients generate incorrect inferences or predictions about motor or sensory function. As an example, a patient may have such a strong internal prediction/inference/belief that the leg is “absent” that this overrides normal sensory input suggesting otherwise. This mechanism is similar to one proposed for phantom limb syndrome, in which the brain has such a strong prediction that a leg is “present” that it overrides sensory input which should correct that prediction.</p><p class="headingAnchor" id="H518775656"><span class="h3">Psychodynamic models</span><span class="headingEndMark"> — </span>The classic psychodynamic hypothesis, which gave rise to the name conversion disorder, is that patients experience an unconscious conflict that is converted into a somatic symptom [<a href="#rid67">67-69</a>]. The symptom serves as a defense against anxiety and distress, which are mitigated by the conflict remaining unconscious [<a href="#rid45">45</a>]. In this model, the conversion symptom symbolizes the conflict and is hypothesized to help the patient avoid an overwhelming situation [<a href="#rid70">70</a>]. The hypothesis is difficult to test scientifically, has been hard to apply clinically, and has limited empirical support [<a href="#rid45">45</a>].</p><p>Subsequent psychodynamic hypotheses emphasize abnormal interpersonal relationships that develop in the context of problematic early relationships (eg, poor parenting) or traumatic events [<a href="#rid42">42</a>]. In these models, a new conflict or traumatic event leads to recurrence of previous patterns of abnormal behavior and the development of physical symptoms. The physical symptoms are regarded as a coping response, secondary to emotional dysregulation. As an example, somatic symptoms that lead to contact with clinicians may enable patients to meet dependency needs established earlier in life.</p><p>Evidence supporting the psychodynamic model includes a retrospective study that assessed patients with functional neurological symptom disorder (n = 43) and patients with depression (n = 28) for stressors prior to symptom onset, and asked healthy controls (n = 28) about stressors in the prior two years [<a href="#rid41">41</a>]. The stressors/life events were rated for the extent to which they could be described as “escape” events,” that is, events which enabled the person to escape from an aversive situation or ameliorate the stressor (eg, providing an “escape” from going to work and facing an abusive boss). The frequency of these “escape” life events in the month before symptom onset was greater for patients with functional neurological symptom disorder, than for patients with depression and healthy controls (53 versus 14 and 0 percent).</p><p>Although evidence for psychodynamic models is limited, therapy based on psychodynamic and interpersonal principles may still be useful.</p><p class="headingAnchor" id="H13156138"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Prognosis for functional neurological symptom disorder (conversion disorder) is frequently poor. Reviews of observational studies suggest that symptoms persist or worsen in approximately 40 to 66 percent of patients [<a href="#rid40">40</a>]. As an example, a 14-year prospective study of 107 patients with functional limb weakness found that symptoms remitted in 20 percent, improved in 31 percent, persisted in 23 percent, and worsened in 26 percent [<a href="#rid71">71</a>]. Most follow-up studies have also found persistent physical symptoms (eg, fatigue and pain) and impaired quality of life [<a href="#rid40">40</a>].</p><p>In addition, prognosis may vary across subtypes of functional neurological symptom disorder:</p><p class="bulletIndent1"><span class="glyph">●</span>Sensory symptoms [<a href="#rid72">72,73</a>] may have a better prognosis than weakness/paralysis [<a href="#rid73">73</a>], dystonia [<a href="#rid74">74</a>], and tremor [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prognosis of functional seizures varies but is often poor. In a systematic review of 25 observational studies, seizure remission occurred in 40 percent or fewer patients [<a href="#rid40">40</a>].</p><p></p><p>Baseline predictors of outcome in patients with functional neurological symptom disorder vary among studies, and much of what is known comes from studies that included not only patients with functional neurological symptom disorder, but other somatic symptom and related disorders as well. In addition, these baseline factors are not consistently associated with outcome across multiple studies and do not enable clinicians to accurately predict outcome for a specific patient.</p><p>Across different studies with follow-up ranging from 8 months to 14 years, prognostic factors included the following (<a class="graphic graphic_table graphicRef138865" href="/z/d/graphic/138865.html" rel="external">table 2</a>) [<a href="#rid4">4,23,39,40,44,71,73,75-81</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Factors associated with a positive outcome:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Onset in childhood or adolescence</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Early diagnosis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Comorbid anxiety or depression</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Subsequent change in marital status</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Good therapeutic alliance with the clinician</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Good response to initial treatment</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Factors associated with a poor outcome:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Multiple physical symptoms</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Longer duration of symptoms (eg, 15 months)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Poor physical functioning</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Comorbid personality disorder</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Beliefs that symptoms are irreversible and caused by a disease with a known pathologic basis – Beliefs that symptoms are not potentially reversible may be a stronger predictor of poor prognosis than the number of conversion symptoms or severity of disability</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Illness-related financial benefits</p><p></p><p class="headingAnchor" id="H13157420"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – The estimated prevalence of functional neurological symptom disorder (conversion disorder) in the general population ranges from 0.004 to 0.2 percent, and in clinical settings, from 2 to 6 percent. Sociodemographic correlates include younger age and female sex. Onset of functional neurological symptom disorder may occur at any age but is rare before age 10 years. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology and pathogenesis</strong> – The etiology and pathogenesis of functional neurological symptom disorder are not fully understood. However, many factors have been identified that may predispose patients to the disorder, may precipitate its onset, and/or perpetuate it (<a class="graphic graphic_table graphicRef88079" href="/z/d/graphic/88079.html" rel="external">table 1</a>). (See <a class="local">'Etiology and pathogenesis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Predisposing factors</strong> – Pre-existing psychiatric medical and neurologic conditions may predispose patients to developing functional neurological symptom disorder. It may also be triggered by physical injury and neurologic illnesses. (See <a class="local">'Predisposing, precipitating, and perpetuating factors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Precipitating factors</strong> – Psychological factors or life events such as trauma, interpersonal conflicts, and recent or old stressors may be associated with onset of the disorder. However, psychological factors are not always reported and they are not specific to functional neurological symptom disorder. In addition, many patients may not have identifiable psychological factors. (See <a class="local">'Predisposing, precipitating, and perpetuating factors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Perpetuating factors</strong> – Functional neurologic symptoms may be inadvertently perpetuated by clinicians in multiple ways, such as failing to give a clear explanation and positive diagnosis, excessively investigating symptoms, misattributing symptoms to a disease or incidental radiologic or laboratory findings, prescribing inappropriate drugs, and performing unnecessary operations. (See <a class="local">'Other perpetuating factors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Etiologic hypotheses</strong> – Hypothetical etiologic models that are not mutually exclusive include the following:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Cognitive-behavioral models</strong> – Cognitive-behavioral models are based upon evidence that processing of perception and behavior mostly occurs outside of awareness, selective attentional bias amplifies minor physiological stimuli and asymmetries, and that functional symptoms involve dissociative experiences and maladaptive thoughts. (See <a class="local">'Cognitive-behavioral models'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Neurobiologic models</strong> – Functional neurological symptom disorder may involve abnormalities in neural networks of grey matter brain regions. Networks involved in attention and the brain’s sense of self-agency, as well as interactions between limbic and motor networks, have been implicated. Another model suggests the disorder arises when patients generate incorrect inferences or predictions about motor or sensory function. (See <a class="local">'Neurobiologic models'</a> above.)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Psychodynamic models</strong> – The classic psychodynamic model hypothesizes that patients experience an unconscious conflict that is converted into a somatic symptom. The symptom is a defense against anxiety and distress, which are reduced by the conflict remaining unconscious. Subsequent models have emphasized abnormal interpersonal relationships that develop in the context of problematic early relationships or traumatic events. (See <a class="local">'Psychodynamic models'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – The prognosis for functional neurological symptom disorder is generally poor. Factors associated with positive and poor outcomes are listed in the table (<a class="graphic graphic_table graphicRef138865" href="/z/d/graphic/138865.html" rel="external">table 2</a>). (See <a class="local">'Prognosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022.</li><li><a class="nounderline abstract_t">Stone J, Carson A, Duncan R, et al. Who is referred to neurology clinics?--the diagnoses made in 3781 new patients. Clin Neurol Neurosurg 2010; 112:747.</a></li><li><a class="nounderline abstract_t">Carson A, Stone J, Hibberd C, et al. Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'. J Neurol Neurosurg Psychiatry 2011; 82:810.</a></li><li><a class="nounderline abstract_t">Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry 2014; 85:220.</a></li><li><a class="nounderline abstract_t">Durrant J, Rickards H, Cavanna AE. Prognosis and outcome predictors in psychogenic nonepileptic seizures. Epilepsy Res Treat 2011; 2011:274736.</a></li><li class="breakAll">Carson A, Lehn A. Epidemiology. In: Handbook of Clinical Neurology: Functional Neurological Disorders, 2016. Vol 139, p.47.</li><li><a class="nounderline abstract_t">Ahmad O, Ahmad KE. Functional neurological disorders in outpatient practice: An Australian cohort. J Clin Neurosci 2016; 28:93.</a></li><li><a class="nounderline abstract_t">Beharry J, Palmer D, Wu T, et al. Functional neurological disorders presenting as emergencies to secondary care. Eur J Neurol 2021; 28:1441.</a></li><li><a class="nounderline abstract_t">Lehn A, Watson E, Ryan EG, et al. Psychogenic nonepileptic seizures treated as epileptic seizures in the emergency department. Epilepsia 2021; 62:2416.</a></li><li><a class="nounderline abstract_t">Lidstone SC, Costa-Parke M, Robinson EJ, et al. Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases. J Neurol Neurosurg Psychiatry 2022; 93:609.</a></li><li><a class="nounderline abstract_t">Ewald H, Rogne T, Ewald K, Fink P. Somatization in patients newly admitted to a neurological department. Acta Psychiatr Scand 1994; 89:174.</a></li><li><a class="nounderline abstract_t">Weddington WW Jr. Conversion reaction in an 82-year-old man. J Nerv Ment Dis 1979; 167:368.</a></li><li><a class="nounderline abstract_t">O'Connell N, Nicholson TR, Wessely S, David AS. Characteristics of patients with motor functional neurological disorder in a large UK mental health service: a case-control study. Psychol Med 2020; 50:446.</a></li><li><a class="nounderline abstract_t">Goldstein LH, Robinson EJ, Reuber M, et al. Characteristics of 698 patients with dissociative seizures: A UK multicenter study. Epilepsia 2019; 60:2182.</a></li><li><a class="nounderline abstract_t">Stephen CD, Fung V, Lungu CI, Espay AJ. Assessment of Emergency Department and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders. JAMA Neurol 2021; 78:88.</a></li><li><a class="nounderline abstract_t">Hallett M, Aybek S, Dworetzky BA, et al. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol 2022; 21:537.</a></li><li><a class="nounderline abstract_t">Perez DL, Aybek S, Popkirov S, et al. A Review and Expert Opinion on the Neuropsychiatric Assessment of Motor Functional Neurological Disorders. J Neuropsychiatry Clin Neurosci 2021; 33:14.</a></li><li><a class="nounderline abstract_t">Baslet G, Bajestan SN, Aybek S, et al. Evidence-Based Practice for the Clinical Assessment of Psychogenic Nonepileptic Seizures: A Report From the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci 2021; 33:27.</a></li><li><a class="nounderline abstract_t">Ludwig L, Pasman JA, Nicholson T, et al. Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies. Lancet Psychiatry 2018; 5:307.</a></li><li><a class="nounderline abstract_t">Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain 2010; 133:1537.</a></li><li><a class="nounderline abstract_t">Brown RJ, Reuber M. Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): A systematic review. Clin Psychol Rev 2016; 45:157.</a></li><li><a class="nounderline abstract_t">Stone J, Warlow C, Deary I, Sharpe M. Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study. J Neuropsychiatry Clin Neurosci 2020; 32:50.</a></li><li><a class="nounderline abstract_t">Crimlisk HL, Bhatia K, Cope H, et al. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 1998; 316:582.</a></li><li><a class="nounderline abstract_t">Kutlubaev MA, Xu Y, Hackett ML, Stone J. Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes. Epilepsy Behav 2018; 89:70.</a></li><li><a class="nounderline abstract_t">Stone J, Carson A, Aditya H, et al. The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review. J Psychosom Res 2009; 66:383.</a></li><li><a class="nounderline abstract_t">Pareés I, Kojovic M, Pires C, et al. Physical precipitating factors in functional movement disorders. J Neurol Sci 2014; 338:174.</a></li><li><a class="nounderline abstract_t">Bautista RE, Gonzales-Salazar W, Ochoa JG. Expanding the theory of symptom modeling in patents with psychogenic nonepileptic seizures. Epilepsy Behav 2008; 13:407.</a></li><li><a class="nounderline abstract_t">Hankey GJ, Stewart-Wynne EG. Pseudo-multiple sclerosis: a clinico-epidemiological study. Clin Exp Neurol 1987; 24:11.</a></li><li><a class="nounderline abstract_t">Barnert C. Conversion reactions and psychophysiologic disorders: a comparative study. Psychiatry Med 1971; 2:205.</a></li><li><a class="nounderline abstract_t">Chabrol H, Peresson G, Clanet M. Lack of specificity of the traditional criteria for conversion disorders. Eur Psychiatry 1995; 10:317.</a></li><li><a class="nounderline abstract_t">Nazir FS, Lees KR, Bone I. Clinical features associated with medically unexplained stroke-like symptoms presenting to an acute stroke unit. Eur J Neurol 2005; 12:81.</a></li><li><a class="nounderline abstract_t">Roy A. Hysteria. J Psychosom Res 1980; 24:53.</a></li><li><a class="nounderline abstract_t">Perry CG, Holmes KG, Gruber-Baldini AL, et al. Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers? Mov Disord Clin Pract 2017; 4:62.</a></li><li><a class="nounderline abstract_t">Friedman JH, LaFrance WC Jr. Psychogenic disorders: the need to speak plainly. Arch Neurol 2010; 67:753.</a></li><li><a class="nounderline abstract_t">Crimlisk HL, Bhatia KP, Cope H, et al. Patterns of referral in patients with medically unexplained motor symptoms. J Psychosom Res 2000; 49:217.</a></li><li><a class="nounderline abstract_t">Williams S, Southall C, Haley S, et al. To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders. J Neurol Sci 2022; 437:120251.</a></li><li><a class="nounderline abstract_t">Nicholson C, Edwards MJ, Carson AJ, et al. Occupational therapy consensus recommendations for functional neurological disorder. J Neurol Neurosurg Psychiatry 2020; 91:1037.</a></li><li><a class="nounderline abstract_t">Brinjikji W, Luetmer PH, Comstock B, et al. Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiol 2015; 36:811.</a></li><li><a class="nounderline abstract_t">Shipston-Sharman O, Popkirov S, Hansen CH, et al. Prognosis in functional and recognised pathophysiological neurological disorders - a shared basis. J Psychosom Res 2021; 152:110681.</a></li><li><a class="nounderline abstract_t">Gelauff J, Stone J. Prognosis of functional neurologic disorders. Handb Clin Neurol 2016; 139:523.</a></li><li><a class="nounderline abstract_t">Nicholson TR, Aybek S, Craig T, et al. Life events and escape in conversion disorder. Psychol Med 2016; 46:2617.</a></li><li class="breakAll">Carson A, Ludwig L, Welch K. Psychologic theories in functional neurologic disorders. In: Handbook of Clinical Neurology: Functional Neurologic Disorders, Elsevier, Cambridge 2016. p.105.</li><li><a class="nounderline abstract_t">Edwards MJ, Adams RA, Brown H, et al. A Bayesian account of 'hysteria'. Brain 2012; 135:3495.</a></li><li><a class="nounderline abstract_t">Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry 2012; 83:842.</a></li><li><a class="nounderline abstract_t">Roelofs K, Spinhoven P. Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev 2007; 27:798.</a></li><li><a class="nounderline abstract_t">Stone J, Warlow C, Sharpe M. Functional weakness: clues to mechanism from the nature of onset. J Neurol Neurosurg Psychiatry 2012; 83:67.</a></li><li><a class="nounderline abstract_t">Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004; 127:2360.</a></li><li><a class="nounderline abstract_t">Pareés I, Saifee TA, Kojovic M, et al. Functional (psychogenic) symptoms in Parkinson's disease. Mov Disord 2013; 28:1622.</a></li><li><a class="nounderline abstract_t">Hoeritzauer I, Carson A, Statham P, et al. Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study. Neurology 2021; 96:e433.</a></li><li><a class="nounderline abstract_t">Lempert T, Schmidt D. Natural history and outcome of psychogenic seizures: a clinical study in 50 patients. J Neurol 1990; 237:35.</a></li><li><a class="nounderline abstract_t">Goldstein LH, Mellers JD. Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures. J Neurol Neurosurg Psychiatry 2006; 77:616.</a></li><li><a class="nounderline abstract_t">Stone J, Carson AJ. The unbearable lightheadedness of seizing: wilful submission to dissociative (non-epileptic) seizures. J Neurol Neurosurg Psychiatry 2013; 84:822.</a></li><li><a class="nounderline abstract_t">Hendrickson R, Popescu A, Dixit R, et al. Panic attack symptoms differentiate patients with epilepsy from those with psychogenic nonepileptic spells (PNES). Epilepsy Behav 2014; 37:210.</a></li><li><a class="nounderline abstract_t">Indranada AM, Mullen SA, Duncan R, et al. The association of panic and hyperventilation with psychogenic non-epileptic seizures: A systematic review and meta-analysis. Seizure 2018; 59:108.</a></li><li><a class="nounderline abstract_t">Dimaro LV, Dawson DL, Roberts NA, et al. Anxiety and avoidance in psychogenic nonepileptic seizures: the role of implicit and explicit anxiety. Epilepsy Behav 2014; 33:77.</a></li><li><a class="nounderline abstract_t">Demartini B, Petrochilos P, Ricciardi L, et al. The role of alexithymia in the development of functional motor symptoms (conversion disorder). J Neurol Neurosurg Psychiatry 2014; 85:1132.</a></li><li><a class="nounderline abstract_t">Popkirov S, Hoeritzauer I, Colvin L, et al. Complex regional pain syndrome and functional neurological disorders - time for reconciliation. J Neurol Neurosurg Psychiatry 2019; 90:608.</a></li><li><a class="nounderline abstract_t">Maurer CW, LaFaver K, Ameli R, et al. Impaired self-agency in functional movement disorders: A resting-state fMRI study. Neurology 2016; 87:564.</a></li><li class="breakAll">Aybek S, Vuilleumier P. Imaging studies of functional neurologic disorders. In: Handbook of Clinical Neurology: Functional Neurologic Disorders, Elsevier, Cambridge 2016. p.73.</li><li><a class="nounderline abstract_t">Aybek S, Nicholson TR, Zelaya F, et al. Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry 2014; 71:52.</a></li><li><a class="nounderline abstract_t">Diez I, Ortiz-Terán L, Williams B, et al. Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder. J Neurol Neurosurg Psychiatry 2019; 90:929.</a></li><li><a class="nounderline abstract_t">Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology 2010; 74:223.</a></li><li><a class="nounderline abstract_t">Baek K, Doñamayor N, Morris LS, et al. Impaired awareness of motor intention in functional neurological disorder: implications for voluntary and functional movement. Psychol Med 2017; 47:1624.</a></li><li><a class="nounderline abstract_t">Maurer CW, LaFaver K, Limachia GS, et al. Gray matter differences in patients with functional movement disorders. Neurology 2018; 91:e1870.</a></li><li><a class="nounderline abstract_t">Bègue I, Adams C, Stone J, Perez DL. Structural alterations in functional neurological disorder and related conditions: a software and hardware problem? Neuroimage Clin 2019; 22:101798.</a></li><li><a class="nounderline abstract_t">Paredes-Echeverri S, Maggio J, Bègue I, et al. Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis. J Neuropsychiatry Clin Neurosci 2022; 34:30.</a></li><li><a class="nounderline abstract_t">Stone J, LaFrance WC Jr, Levenson JL, Sharpe M. Issues for DSM-5: Conversion disorder. Am J Psychiatry 2010; 167:626.</a></li><li><a class="nounderline abstract_t">Stone J, Carson A, Sharpe M. Functional symptoms in neurology: management. J Neurol Neurosurg Psychiatry 2005; 76 Suppl 1:i13.</a></li><li class="breakAll">Abbey SE, Wulsin L, Levenson JL. Somatization and somatoform disorders. In: The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, Second Edition, Levenson JL (Ed), American Psychiatric Publishing, Inc., Washington, DC 2011. p.261.</li><li class="breakAll">Maldonado JR. Conversion disorder. In: Gabbard's Treatments of Psychiatric Disorders, Fourth Edition, Gabbard GO (Ed), American Psychiatric Publishing, Inc., Washington, DC 2007. p.595.</li><li><a class="nounderline abstract_t">Gelauff JM, Carson A, Ludwig L, et al. The prognosis of functional limb weakness: a 14-year case-control study. Brain 2019; 142:2137.</a></li><li><a class="nounderline abstract_t">Toth C. Hemisensory syndrome is associated with a low diagnostic yield and a nearly uniform benign prognosis. J Neurol Neurosurg Psychiatry 2003; 74:1113.</a></li><li><a class="nounderline abstract_t">Stone J, Sharpe M, Rothwell PM, Warlow CP. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2003; 74:591.</a></li><li><a class="nounderline abstract_t">Ibrahim NM, Martino D, van de Warrenburg BP, et al. The prognosis of fixed dystonia: a follow-up study. Parkinsonism Relat Disord 2009; 15:592.</a></li><li><a class="nounderline abstract_t">Sharpe M, Stone J, Hibberd C, et al. Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome. Psychol Med 2010; 40:689.</a></li><li><a class="nounderline abstract_t">Duncan R, Razvi S, Mulhern S. Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic. Epilepsy Behav 2011; 20:308.</a></li><li><a class="nounderline abstract_t">Jankovic J, Vuong KD, Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr 2006; 11:501.</a></li><li><a class="nounderline abstract_t">Carson AJ, Best S, Postma K, et al. The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study. J Neurol Neurosurg Psychiatry 2003; 74:897.</a></li><li><a class="nounderline abstract_t">Mace CJ, Trimble MR. Ten-year prognosis of conversion disorder. Br J Psychiatry 1996; 169:282.</a></li><li><a class="nounderline abstract_t">Couprie W, Wijdicks EF, Rooijmans HG, van Gijn J. Outcome in conversion disorder: a follow up study. J Neurol Neurosurg Psychiatry 1995; 58:750.</a></li><li><a class="nounderline abstract_t">Binzer M, Kullgren G. Motor conversion disorder. A prospective 2- to 5-year follow-up study. Psychosomatics 1998; 39:519.</a></li></ol></div><div id="topicVersionRevision">Topic 85764 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision, American Psychiatric Association, Washington, DC 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20646830" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Who is referred to neurology clinics?--the diagnoses made in 3781 new patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21257981" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24029543" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : The prognosis of functional (psychogenic) motor symptoms: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22937230" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prognosis and outcome predictors in psychogenic nonepileptic seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22937230" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Prognosis and outcome predictors in psychogenic nonepileptic seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26754851" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Functional neurological disorders in outpatient practice: An Australian cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33426732" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Functional neurological disorders presenting as emergencies to secondary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34396517" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Psychogenic nonepileptic seizures treated as epileptic seizures in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35217516" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Functional movement disorder gender, age and phenotype study: a systematic review and individual patient meta-analysis of 4905 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8178675" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Somatization in patients newly admitted to a neurological department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/448341" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Conversion reaction in an 82-year-old man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30773149" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Characteristics of patients with motor functional neurological disorder in a large UK mental health service: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31608436" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Characteristics of 698 patients with dissociative seizures: A UK multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33104173" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Assessment of Emergency Department and Inpatient Use and Costs in Adult and Pediatric Functional Neurological Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35430029" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Functional neurological disorder: new subtypes and shared mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32778007" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A Review and Expert Opinion on the Neuropsychiatric Assessment of Motor Functional Neurological Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32778006" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Evidence-Based Practice for the Clinical Assessment of Psychogenic Nonepileptic Seizures: A Report From the American Neuropsychiatric Association Committee on Research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29526521" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Stressful life events and maltreatment in conversion (functional neurological) disorder: systematic review and meta-analysis of case-control studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20395262" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The symptom of functional weakness: a controlled study of 107 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27084446" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31466514" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Predisposing Risk Factors for Functional Limb Weakness: A Case-Control Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9518908" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30384103" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Dual diagnosis of epilepsy and psychogenic nonepileptic seizures: Systematic review and meta-analysis of frequency, correlates, and outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19379954" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The role of physical injury in motor and sensory conversion symptoms: a systematic and narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24439198" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Physical precipitating factors in functional movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18522872" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Expanding the theory of symptom modeling in patents with psychogenic nonepileptic seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3268335" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pseudo-multiple sclerosis: a clinico-epidemiological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4112643" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Conversion reactions and psychophysiologic disorders: a comparative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19698360" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Lack of specificity of the traditional criteria for conversion disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15679694" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Clinical features associated with medically unexplained stroke-like symptoms presenting to an acute stroke unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7411495" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Hysteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30713949" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Are Patients with Psychogenic Movement Disorders More Likely to be Healthcare Workers?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20558396" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Psychogenic disorders: the need to speak plainly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11110993" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Patterns of referral in patients with medically unexplained motor symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35429701" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32732388" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Occupational therapy consensus recommendations for functional neurological disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25430861" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Systematic literature review of imaging features of spinal degeneration in asymptomatic populations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34872006" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prognosis in functional and recognised pathophysiological neurological disorders - a shared basis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27719869" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prognosis of functional neurologic disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27377290" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Life events and escape in conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27377290" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Life events and escape in conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22641838" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A Bayesian account of 'hysteria'.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22661497" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Functional (conversion) neurological symptoms: research since the millennium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17728032" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21836030" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Functional weakness: clues to mechanism from the nature of onset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15342362" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The syndrome of fixed dystonia: an evaluation of 103 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23737007" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Functional (psychogenic) symptoms in Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33177221" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2319265" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Natural history and outcome of psychogenic seizures: a clinical study in 50 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16614021" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23538071" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The unbearable lightheadedness of seizing: wilful submission to dissociative (non-epileptic) seizures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25084477" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Panic attack symptoms differentiate patients with epilepsy from those with psychogenic nonepileptic spells (PNES).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29787922" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The association of panic and hyperventilation with psychogenic non-epileptic seizures: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24632427" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Anxiety and avoidance in psychogenic nonepileptic seizures: the role of implicit and explicit anxiety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24610939" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The role of alexithymia in the development of functional motor symptoms (conversion disorder).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30355604" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Complex regional pain syndrome and functional neurological disorders - time for reconciliation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27385746" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Impaired self-agency in functional movement disorders: A resting-state fMRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27385746" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Impaired self-agency in functional movement disorders: A resting-state fMRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24258270" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Neural correlates of recall of life events in conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30850473" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Corticolimbic fast-tracking: enhanced multimodal integration in functional neurological disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20083798" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The involuntary nature of conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28183377" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Impaired awareness of motor intention in functional neurological disorder: implications for voluntary and functional movement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30305450" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Gray matter differences in patients with functional movement disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31146322" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Structural alterations in functional neurological disorder and related conditions: a software and hardware problem?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34711069" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Autonomic, Endocrine, and Inflammation Profiles in Functional Neurological Disorder: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20516161" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Issues for DSM-5: Conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15718216" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Functional symptoms in neurology: management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15718216" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Functional symptoms in neurology: management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15718216" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Functional symptoms in neurology: management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31167232" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : The prognosis of functional limb weakness: a 14-year case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12876246" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Hemisensory syndrome is associated with a low diagnostic yield and a nearly uniform benign prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12700300" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The 12 year prognosis of unilateral functional weakness and sensory disturbance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19442561" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The prognosis of fixed dystonia: a follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19627646" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Neurology out-patients with symptoms unexplained by disease: illness beliefs and financial benefits predict 1-year outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21195031" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Newly presenting psychogenic nonepileptic seizures: incidence, population characteristics, and early outcome from a prospective audit of a first seizure clinic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16816790" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Psychogenic tremor: long-term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12810775" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8879713" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Ten-year prognosis of conversion disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7608683" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Outcome in conversion disorder: a follow up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9819952" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Motor conversion disorder. A prospective 2- to 5-year follow-up study.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
